本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ra Pharmaceuticals Inc.

48.00
0.0000
成交量:- -
成交额:- -
市值:22.72亿
市盈率:-20.73
高:48.00
开:48.00
低:48.00
收:48.00
52周最高:48.02
52周最低:19.64
股本:4,732.89万
流通股本:3,590.33万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.3147
每股收益(LYR):-2.3147
净资产收益率:-43.77%
总资产收益率:-26.57%
市净率:8.67
市盈率(LYR):-20.73

数据加载中...

2020/04/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

重要事件披露

Current report, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01
2020/04/02

交易所摘牌声明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/03/31

重要事件披露

Current report, item 8.01
2020/03/16

重要事件披露

8-K - Current report
2020/02/28

重要事件披露

8-K - Current report
2020/02/27

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/18

重要事件披露

Current report, items 5.07 and 8.01
2019/11/25

重要事件披露

Current report, item 8.01
2019/11/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

重要事件披露

Current report, items 1.01, 7.01, and 9.01